Early Access — free while we kick the tires
EdgarHawk

David L Mahoney

Director

Director

Latest: Director selling · June 2026

2 filings analyzed · 1 company · Latest 2026-06-18

Companies

Company Buys Sells Direction
CORCEPT THERAPEUTICS INC CORT 0 5 Net selling

Activity

June 2026
high
Sell
20,000 shares
$1,690,506
Significance 7/10

Director Mahoney sells 20,000 CORT shares at $84.53; stock now $81.75 vs $91.00 high; prior 2 sells at CORT both well-timed at 90d.

David L Mahoney sold 20,000 shares (43.3% of his holdings) at $84.53 on 2026-06-17, reducing his stake from 46,147 to 26,147 shares for total proceeds of $1,690,506.00. The stock has since fallen to $81.75, currently -10.2% from its 52-week high of $91.00, placing this sale within a broader positive 30-day (+48.3%) and 90-day (+139.9%) momentum context. Notably, both of his prior sales at CORT (on 2025-05-16) were well-timed at the 90-day mark, with negative post-sale returns of -3.6% and -2.9% respectively, suggesting a pattern of sales preceding declines at this ticker. The company reports a net loss of $31.8M against revenue of $164.9M (latest quarter), with a steep P/E of 185.80 and market cap of $8.8B, indicating significant valuation relative to profitability. This sale, combined with his consistent 90-day timing accuracy on prior CORT sales, warrants tracking of the stock's subsequent performance to confirm whether the pattern holds.

May 2025
high
Sell
27,352 shares
$2,030,452
Significance 8/10

Director David L. Mahoney liquidates entire 27,352-share position in CORT via 2 sales for $2,030,452.50

Director David L. Mahoney sold 23,829 shares at $74.17 and 3,523 shares at $74.65 on 2025-05-16, totaling 27,352 shares for $2,030,452.50 at a blended average price of $74.23. The sale represents a complete liquidation—his post-transaction holdings are 0 shares, down from 27,352 shares pre-transaction (-100.0% of prior holdings). CORT trades at $76.22 currently, approximately 2.7% above the transaction prices, within a 52-week range of $27.52–$114.22. The company reports strong fundamentals: $157.2M in latest quarterly revenue with +39.9% annual growth and $20.5M net income, though the stock commands a 60.49 P/E multiple at $8.1B market cap. The complete exit by a board member warrants scrutiny given the company's growth profile and valuation, particularly to understand whether this reflects personal liquidity needs or a substantive shift in board-level perspective.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access